First results of the French OCTOPUS survey among festival attendees: a latent class analysis

Table 2 Prevalence of the different psychoactive drugs used in the last 12 months in the total population (n = 383) and persons who use psychoactive substances (n = 314)

Psychoactive drug, n (%)	Number of persons who use drugs	Prevalence in the total population N = 383 (%)	Prevalence among the persons who use drugs N = 314 (%)
Cannabis, n (%)	243	63.4	77.4
Ecstasy/MDMA, n (%)	186	48.6	59.2
Cocaine, n (%)	159	41.5	50.6
Speed, n (%)	32	8.4	10.2
Poppers, n (%)	17	4.4	5.4
Other stimulants^a, n (%)	15	3.9	4.8
LSD, n (%)	67	17.5	21.3
Magic mushrooms, n (%)	42	11.0	13.4
Ketamine, n (%)	37	9.7	11.8
Other hallucinogens^b, n (%)	4	1.0	1.3
NPSs^c, n (%)	19	5.0	6.1
Sedatives^d, n (%)	19	5.0	6.1
Cannabidiol	1	0.3	0.3

MDMA Methylenedioxymethamphetamine, LSD Lysergic acid diethylamide, NPSs New psychoactive substances
^aGBL (n = 2), crack (n = 2), Ritalin (n = 1), ephedrine (n = 1), caffeine (n = 1), amphetamine (n = 8)
^bSalvia divinorum (n = 2), mescaline (n = 2)
^cNPSs in detail: Synthetic stimulants (n = 7): mephedrone (n = 3), 3-MMC (n = 2), 4-MEC (n = 1), methylone (n = 1), ethylphenidate (n = 2). Synthetic hallucinogens (n = 10): DMT (n = 4), 5-APB (n = 3), methoxetamine (n = 2), 25C-NBOMe (n = 1), 25I-NBOMe (n = 1), 2C-P (n = 1), 2C-B (n = 2), 2C-E (n = 1), Bk-2C-B (n = 1), DOC (n = 1), deschloroketamine (n = 1). Synthetic opioids (n = 5): U-47700. Synthetic cannabinoids (n = 2)
^dopium (n = 7), heroin (n = 5), methadone (n = 2), nitrous oxide (n = 2), tramadol (n = 2), Valium (n = 2), codeine (n = 1), Skenan (n = 1), Xanax (n = 1)

ISSN: 1477-7517